GB202204231D0 - Retinal Disorders - Google Patents

Retinal Disorders

Info

Publication number
GB202204231D0
GB202204231D0 GBGB2204231.1A GB202204231A GB202204231D0 GB 202204231 D0 GB202204231 D0 GB 202204231D0 GB 202204231 A GB202204231 A GB 202204231A GB 202204231 D0 GB202204231 D0 GB 202204231D0
Authority
GB
United Kingdom
Prior art keywords
retinal disorders
retinal
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2204231.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ikarovec Ltd
Original Assignee
Ikarovec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikarovec Ltd filed Critical Ikarovec Ltd
Priority to GBGB2204231.1A priority Critical patent/GB202204231D0/en
Publication of GB202204231D0 publication Critical patent/GB202204231D0/en
Priority to JP2023577965A priority patent/JP2024525183A/en
Priority to EP22735972.6A priority patent/EP4355886A1/en
Priority to US18/570,692 priority patent/US20240279680A1/en
Priority to AU2022295135A priority patent/AU2022295135A1/en
Priority to CA3222463A priority patent/CA3222463A1/en
Priority to CN202280055858.0A priority patent/CN117897493A/en
Priority to IL309393A priority patent/IL309393A/en
Priority to PCT/GB2022/051536 priority patent/WO2022263841A1/en
Priority to KR1020247001745A priority patent/KR20240023126A/en
Ceased legal-status Critical Current

Links

GBGB2204231.1A 2021-06-18 2022-03-25 Retinal Disorders Ceased GB202204231D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB2204231.1A GB202204231D0 (en) 2022-03-25 2022-03-25 Retinal Disorders
KR1020247001745A KR20240023126A (en) 2021-06-18 2022-06-17 retinal disorders
AU2022295135A AU2022295135A1 (en) 2021-06-18 2022-06-17 Retinal disorders
EP22735972.6A EP4355886A1 (en) 2021-06-18 2022-06-17 Retinal disorders
US18/570,692 US20240279680A1 (en) 2021-06-18 2022-06-17 Retinal Disorders
JP2023577965A JP2024525183A (en) 2021-06-18 2022-06-17 Retinal disorders
CA3222463A CA3222463A1 (en) 2021-06-18 2022-06-17 Retinal disorders
CN202280055858.0A CN117897493A (en) 2021-06-18 2022-06-17 Retinal disorders
IL309393A IL309393A (en) 2021-06-18 2022-06-17 Retinal disorders
PCT/GB2022/051536 WO2022263841A1 (en) 2021-06-18 2022-06-17 Retinal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2204231.1A GB202204231D0 (en) 2022-03-25 2022-03-25 Retinal Disorders

Publications (1)

Publication Number Publication Date
GB202204231D0 true GB202204231D0 (en) 2022-05-11

Family

ID=81449414

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2204231.1A Ceased GB202204231D0 (en) 2021-06-18 2022-03-25 Retinal Disorders

Country Status (2)

Country Link
CN (1) CN117897493A (en)
GB (1) GB202204231D0 (en)

Also Published As

Publication number Publication date
CN117897493A (en) 2024-04-16

Similar Documents

Publication Publication Date Title
EP4010072A4 (en) Treatment of central nervous system disorders
EP4076422A4 (en) Methods for improving neurological diseases and disorders
IL287280A (en) Compounds and methods for the treatment of ocular disorders
EP3806847A4 (en) Methods for improving neurological diseases and disorders
EP3927428A4 (en) Methods of treatment of respiratory disorders
IL287264A (en) Compounds and methods for the treatment of ocular disorders
IL275985A (en) Compositions and methods for treating retinal disorders
EP4069847A4 (en) Treatment of lower airways disorders
IL287831A (en) Oxymetazoline compositions and methods for treating ocular disorders
GB201914034D0 (en) Treatment of neurological disorders
EP3890753A4 (en) Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh1 activity
IL268946A (en) Gene therapy for ocular disorders
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
GB202204234D0 (en) Retinal Disorders
GB202204230D0 (en) Retinal Disorders
GB202204231D0 (en) Retinal Disorders
IL309392A (en) Retinal disorders
IL309393A (en) Retinal disorders
GB202108756D0 (en) Retinal disorders
GB202108760D0 (en) Retinal disorders
GB202108759D0 (en) Retinal disorders
IL289221A (en) Compounds for treatment of eye disorders
GB202109675D0 (en) Treatment for tyrosine degradation-associated disorders
GB202020549D0 (en) Treatment for Lysine Degradation-associated Disorders
EP4040991A4 (en) Treatment for gastrointestinal disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)